| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Chardan Capital analyst James McIlree maintains Urgently (NASDAQ:ULY) with a Buy and maintains $15 price target.
Needham analyst Chris Pierce reiterates Urgently (NASDAQ:ULY) with a Buy and maintains $8 price target.
Urgently (NASDAQ:ULY) reported quarterly losses of $(3.63) per share which missed the analyst consensus estimate of $(2.40) by ...